Lina Singleton

Lina Singleton, PharmD, RPh, is a Senior Scientific Director at AbbVie, following ImmunoGen's acquisition. Previously, they served as Senior Director of Solid Tumors Scientific Communications at ImmunoGen, having a robust background in pharmaceutical roles at companies such as Novartis Oncology and Novo Nordisk. Lina began their career as a PRN Pharmacist at Walgreens Pharmacy and completed a Medical Information Residency at Bristol-Myers Squibb. They earned their PharmD from Florida Agricultural and Mechanical University in 2009.